Hanseatic Management Services Inc. Has $591,000 Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Hanseatic Management Services Inc. raised its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) by 5.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,941 shares of the medical device company’s stock after buying an additional 710 shares during the quarter. Hanseatic Management Services Inc.’s holdings in Tandem Diabetes Care were worth $591,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TNDM. Stephens Investment Management Group LLC boosted its position in shares of Tandem Diabetes Care by 12.2% in the third quarter. Stephens Investment Management Group LLC now owns 1,274,482 shares of the medical device company’s stock valued at $54,051,000 after acquiring an additional 138,263 shares during the period. abrdn plc acquired a new stake in Tandem Diabetes Care in the 3rd quarter worth about $6,126,000. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Tandem Diabetes Care by 54.1% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,648 shares of the medical device company’s stock valued at $2,575,000 after purchasing an additional 21,282 shares during the period. Assenagon Asset Management S.A. grew its position in shares of Tandem Diabetes Care by 21.2% during the 3rd quarter. Assenagon Asset Management S.A. now owns 377,565 shares of the medical device company’s stock worth $16,013,000 after purchasing an additional 66,138 shares in the last quarter. Finally, International Assets Investment Management LLC increased its holdings in shares of Tandem Diabetes Care by 4,141.2% during the third quarter. International Assets Investment Management LLC now owns 6,998 shares of the medical device company’s stock worth $297,000 after purchasing an additional 6,833 shares during the period.

Tandem Diabetes Care Stock Up 3.4 %

Shares of NASDAQ:TNDM opened at $34.24 on Thursday. Tandem Diabetes Care, Inc. has a 52-week low of $13.82 and a 52-week high of $53.69. The company has a market capitalization of $2.24 billion, a PE ratio of -16.38 and a beta of 1.36. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.38 and a current ratio of 3.05. The company has a fifty day moving average of $39.21 and a 200-day moving average of $41.88.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Royal Bank of Canada started coverage on Tandem Diabetes Care in a research note on Wednesday, October 2nd. They issued an “outperform” rating and a $65.00 price target for the company. Canaccord Genuity Group began coverage on Tandem Diabetes Care in a report on Thursday, August 8th. They set a “buy” rating and a $57.00 target price on the stock. UBS Group upgraded Tandem Diabetes Care to a “hold” rating in a research report on Friday, August 2nd. Canaccord Genuity Group assumed coverage on shares of Tandem Diabetes Care in a research report on Thursday, August 8th. They set a “buy” rating and a $57.00 price objective for the company. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $45.00 target price on shares of Tandem Diabetes Care in a report on Monday, September 23rd. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $54.31.

Tandem Diabetes Care Company Profile

Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.